EE200300124A - 17alfa-fluoroalküülsteroidid, nende valmistamismeetod ja neid ühendeid sisaldavad farmatseutilised kompositsioonid - Google Patents
17alfa-fluoroalküülsteroidid, nende valmistamismeetod ja neid ühendeid sisaldavad farmatseutilised kompositsioonidInfo
- Publication number
- EE200300124A EE200300124A EEP200300124A EEP200300124A EE200300124A EE 200300124 A EE200300124 A EE 200300124A EE P200300124 A EEP200300124 A EE P200300124A EE P200300124 A EEP200300124 A EE P200300124A EE 200300124 A EE200300124 A EE 200300124A
- Authority
- EE
- Estonia
- Prior art keywords
- compounds
- preparation
- pharmaceutical compositions
- compositions containing
- fluoroalkyl steroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0063—Nitrogen and oxygen at position 2(3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0073—Sulfur-containing hetero ring
- C07J71/0078—Sulfur-containing hetero ring containing only sulfur
- C07J71/0084—Episulfides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10049736A DE10049736A1 (de) | 2000-09-29 | 2000-09-29 | 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| PCT/DE2001/003732 WO2002026759A2 (de) | 2000-09-29 | 2001-09-28 | 17α-FLUORALKYLSTEROIDE, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200300124A true EE200300124A (et) | 2005-04-15 |
Family
ID=7659018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300124A EE200300124A (et) | 2000-09-29 | 2001-09-28 | 17alfa-fluoroalküülsteroidid, nende valmistamismeetod ja neid ühendeid sisaldavad farmatseutilised kompositsioonid |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20040024231A1 (et) |
| EP (1) | EP1322660B1 (et) |
| JP (1) | JP2004509971A (et) |
| KR (1) | KR20030061815A (et) |
| CN (1) | CN1305890C (et) |
| AT (1) | ATE338054T1 (et) |
| AU (1) | AU1382202A (et) |
| BG (1) | BG107763A (et) |
| BR (1) | BR0114258A (et) |
| CA (1) | CA2422056A1 (et) |
| DE (2) | DE10049736A1 (et) |
| DK (1) | DK1322660T3 (et) |
| EA (1) | EA005772B1 (et) |
| EE (1) | EE200300124A (et) |
| ES (1) | ES2272550T3 (et) |
| HK (1) | HK1061860A1 (et) |
| HR (1) | HRP20030334A2 (et) |
| HU (1) | HUP0301198A2 (et) |
| IL (2) | IL154828A0 (et) |
| MX (1) | MXPA03002606A (et) |
| NO (1) | NO325058B1 (et) |
| NZ (1) | NZ524781A (et) |
| PL (1) | PL361666A1 (et) |
| PT (1) | PT1322660E (et) |
| SK (1) | SK5192003A3 (et) |
| UA (1) | UA76125C2 (et) |
| WO (1) | WO2002026759A2 (et) |
| YU (1) | YU22903A (et) |
| ZA (1) | ZA200303216B (et) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
| US20050182322A1 (en) * | 2004-02-17 | 2005-08-18 | Liebel-Flarsheim Company | Injector auto purge |
| EP1854465A1 (en) * | 2006-05-12 | 2007-11-14 | Alexander Tobias Teichmann | Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
| DE102006054535A1 (de) * | 2006-11-15 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | Progesteronrezeptorantagonisten |
| KR101044794B1 (ko) * | 2011-01-05 | 2011-06-27 | 연규백 | 복합판넬에 브이 홈을 컷팅하는 장치 |
| CN102964411B (zh) * | 2012-12-03 | 2015-04-22 | 华中药业股份有限公司 | 一种雄甾-4,6-二烯-17α-甲基-17β-醇-3-酮的合成方法 |
| CN114409717B (zh) * | 2021-12-17 | 2023-03-17 | 湖南科益新生物医药有限公司 | 替勃龙中间体醚化物和替勃龙的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3029261A (en) * | 1959-11-30 | 1962-04-10 | Syntex Sa | Steroidal fluoro compounds and process for the production thereof |
| US3046273A (en) * | 1961-01-18 | 1962-07-24 | Merck & Co Inc | Novel 17alpha-trifluoro-propynyl androstenes and processes |
| US3255182A (en) * | 1961-02-13 | 1966-06-07 | Merck & Co Inc | 17alpha-haloethynyl-[3, 2-c]pyrazolo androstenes and intermediates therefor |
| CH431508A (de) * | 1961-06-16 | 1967-03-15 | Ciba Geigy | Verfahren zur Ketalisierung der 3-Oxogruppe in 5(10)-3-Oxo-19-nor-steroiden |
| US3098851A (en) * | 1961-11-20 | 1963-07-23 | Searle & Co | 17alpha-alkynyl-2beta-halo-5alpha-androstane-3alpha, 17beta-diols, esters thereof, and intermediates thereto |
| US3092623A (en) * | 1961-12-01 | 1963-06-04 | Merck & Co Inc | [3, 2-c] pyrazolo-4, 9-androstadienes |
| US3076825A (en) * | 1962-02-14 | 1963-02-05 | Syntex Corp | 17alpha-(1'-fluoroethyl) and 17alpha-(1', 1'-difluoroethyl) androstane derivatives and process therefor |
| US3340251A (en) * | 1965-10-18 | 1967-09-05 | Merck & Co Inc | 17beta-hydroxy-17alpha-halohydrocarbon-19-nor-androst-4-ene-3-ones and the delta5(10)-isomers thereof |
| AU3257993A (en) * | 1991-12-22 | 1993-07-28 | Schering Aktiengesellschaft | 3-methylsulphonylhydrazono and 3-oxyimino steroids, a method of preparing them, pharmaceutical preparations containing them and their use in the preparation of drugs |
| CN1072678C (zh) * | 1994-05-30 | 2001-10-10 | 中国科学院上海有机化学研究所 | 三氟甲基甾体化合物、制备及其用途 |
| DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
| DE19860719A1 (de) * | 1998-12-23 | 2000-06-29 | Schering Ag | Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen |
| DE10221034A1 (de) * | 2002-05-03 | 2003-11-20 | Schering Ag | 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
-
2000
- 2000-09-29 DE DE10049736A patent/DE10049736A1/de not_active Withdrawn
-
2001
- 2001-09-28 NZ NZ524781A patent/NZ524781A/en unknown
- 2001-09-28 EE EEP200300124A patent/EE200300124A/et unknown
- 2001-09-28 US US10/381,789 patent/US20040024231A1/en not_active Abandoned
- 2001-09-28 IL IL15482801A patent/IL154828A0/xx active IP Right Grant
- 2001-09-28 MX MXPA03002606A patent/MXPA03002606A/es active IP Right Grant
- 2001-09-28 CN CNB018165494A patent/CN1305890C/zh not_active Expired - Fee Related
- 2001-09-28 UA UA2003043904A patent/UA76125C2/uk unknown
- 2001-09-28 AT AT01982167T patent/ATE338054T1/de not_active IP Right Cessation
- 2001-09-28 ES ES01982167T patent/ES2272550T3/es not_active Expired - Lifetime
- 2001-09-28 DE DE50110892T patent/DE50110892D1/de not_active Expired - Fee Related
- 2001-09-28 EA EA200300400A patent/EA005772B1/ru not_active IP Right Cessation
- 2001-09-28 PT PT01982167T patent/PT1322660E/pt unknown
- 2001-09-28 CA CA002422056A patent/CA2422056A1/en not_active Abandoned
- 2001-09-28 WO PCT/DE2001/003732 patent/WO2002026759A2/de active IP Right Grant
- 2001-09-28 BR BR0114258-5A patent/BR0114258A/pt not_active IP Right Cessation
- 2001-09-28 KR KR10-2003-7004483A patent/KR20030061815A/ko active IP Right Grant
- 2001-09-28 HU HU0301198A patent/HUP0301198A2/hu unknown
- 2001-09-28 SK SK519-2003A patent/SK5192003A3/sk unknown
- 2001-09-28 AU AU1382202A patent/AU1382202A/xx not_active Withdrawn
- 2001-09-28 JP JP2002531142A patent/JP2004509971A/ja active Pending
- 2001-09-28 EP EP01982167A patent/EP1322660B1/de not_active Expired - Lifetime
- 2001-09-28 YU YU22903A patent/YU22903A/sh unknown
- 2001-09-28 DK DK01982167T patent/DK1322660T3/da active
- 2001-09-28 PL PL01361666A patent/PL361666A1/xx unknown
-
2003
- 2003-03-10 IL IL154828A patent/IL154828A/en not_active IP Right Cessation
- 2003-03-28 NO NO20031444A patent/NO325058B1/no unknown
- 2003-04-24 ZA ZA200303216A patent/ZA200303216B/en unknown
- 2003-04-25 BG BG107763A patent/BG107763A/bg unknown
- 2003-04-28 HR HR20030334A patent/HRP20030334A2/hr not_active Application Discontinuation
-
2004
- 2004-07-06 HK HK04104883A patent/HK1061860A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| ES2174629T3 (es) | 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos. | |
| FI954898A (fi) | Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina | |
| IT1271325B (it) | Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni | |
| EE200300124A (et) | 17alfa-fluoroalküülsteroidid, nende valmistamismeetod ja neid ühendeid sisaldavad farmatseutilised kompositsioonid | |
| SE9904128D0 (sv) | Novel compounds | |
| TR200001405T2 (tr) | 11ß pozisyonunda ikameli/katkılı yeni 19-nor steroidler hazırlama metodu-ara maddeleri. | |
| YU51199A (sh) | Novi 4-halogeni steroidi, postupak i međuproizvodi za njihovo pripremanje, njihova primena kao medikamenata i farmaceutske kompozicije koje ih sadrže | |
| AU1200097A (en) | 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them | |
| EE200200302A (et) | Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid | |
| HUP0301332A2 (hu) | Új mono- és biszmetilén-szteroid-származékok és eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| AU2507501A (en) | 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds | |
| TW200603812A (en) | D-homo-17-chlor-16(17)-ene steroids | |
| ES2182785T3 (es) | Nuevos derivados de esteroides 11,beta-sustituidos, sus procedimientos de preparacion y los intermedios de este procedimiento, su aplicacion como medicamentos y composiciones que los contienen. |